Results 201 to 210 of about 2,862,152 (305)

Experimental evaluation of dermal lymphatics in preservation of lymphatic function. [PDF]

Breast Cancer Res
Hulsman L, Mohan G, Sidhu AS, Ahmed S, Sullivan SJ, Subi-Kasozi CA, Mahariq AR, Jorge MD, Sinha M, Hassanein AH.   +9 more
europepmc   +1 more source

Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin

Molecular Oncology, EarlyView.
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon, Dong Young Kim, Yuna Kim, Uk‐Il Kim, Jae‐Sung Kim   +4 more
wiley   +1 more source

Clear cell renal cell carcinoma with collecting duct carcinoma transformation: a case report and review of the literature. [PDF]

BMC Urol
Liang M, Li L, Cao Y, Zhang K, Fu Q.
europepmc   +1 more source

RaMBat: Accurate identification of medulloblastoma subtypes from diverse data sources with severe batch effects

Molecular Oncology, EarlyView.
To integrate multiple transcriptomics data with severe batch effects for identifying MB subtypes, we developed a novel and accurate computational method named RaMBat, which leveraged subtype‐specific gene expression ranking information instead of absolute gene expression levels to address batch effects of diverse data sources.
Mengtao Sun, Jieqiong Wang, Shibiao Wan
wiley   +1 more source

Salvage of a Blocked Nephrostomy Catheter Using Needle Recanalization-SURE (Sharp Urologic REcanalization) Technique. [PDF]

Interv Radiol (Higashimatsuyama)
Loi KS, Rahim RA.
europepmc   +1 more source

Colorectal cancer‐derived FGF19 is a metabolically active serum biomarker that exerts enteroendocrine effects on mouse liver

Molecular Oncology, EarlyView.
Meta‐transcriptome analysis identified FGF19 as a peptide enteroendocrine hormone associated with colorectal cancer prognosis. In vivo xenograft models showed release of FGF19 into the blood at levels that correlated with tumor volumes. Tumoral‐FGF19 altered murine liver metabolism through FGFR4, thereby reducing bile acid synthesis and increasing ...
Jordan M. Beardsley, Michael W. Rohr, Joseph A. Goode, Sai Preethi Nakkina, Jignesh G. Parikh, Deborah A. Altomare   +5 more
wiley   +1 more source

Collecting Social Determinants of Health in a Children's Oncology Group Trial for High-Risk Neuroblastoma.

JAMA Netw Open
Jones E, Naranjo A, Winestone LE, Umaretiya PJ, Aziz-Bose R, Kelly CA, Newman H, Zheng DJ, Greengard E, Bagatell R, DuBois SG, Bona K.   +11 more
europepmc   +1 more source

Difference-making pathways to implementing systematic, partial, or no data collection of sexual orientation and gender identity in oncology settings: a coincidence analysis. [PDF]

Support Care Cancer
Pratt-Chapman ML, Miech EJ, Mullins MA, Gold BO, Rosenberg D, Insalaco ME, Kamen C.   +6 more
europepmc   +1 more source

Identification of serum protein biomarkers for pre‐cancerous lesions associated with pancreatic ductal adenocarcinoma

Molecular Oncology, EarlyView.
This work identified serum proteins associated with pancreatic epithelial neoplasms (PanINs) and early‐stage PDAC. Proteomics screens assessed genetically engineered mice with abundant PanINs, KPC mice (Lox‐STOP‐Lox‐KrasG12D/+ Lox‐STOP‐Lox‐Trp53R172H/+ Pdx1‐Cre) before PDAC development and also early‐stage PDAC patients (n = 31), compared to benign ...
Hannah Mearns, Jaclyn S. Long, Sergio Lilla, Kelly Hodge, Marcus J. G. W. Ladds, Colin Nixon, Paula Fernández‐Palanca, Sara Zanivan, Pilar Acedo, Stephen P. Pereira, Kevin M. Ryan   +10 more
wiley   +1 more source